Medications for Processing Deficient Progeroid Laminopathies (PDPL)

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Processing Deficient Progeroid Laminopathies (PDPL).

Found 1 Approved Drug for Processing Deficient Progeroid Laminopathies (PDPL)

Zokinvy

Generic Name
Lonafarnib

Zokinvy

Generic Name
Lonafarnib
Form: Capsule
Method of administration: Oral
FDA approval date: November 20, 2020
Classification: Farnesyltransferase Inhibitor
ZOKINVY is indicated in patients 12 months of age and older with a body surface area (BSA) of.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances